CTRI/2020/02/023317尚未招募4 期
A randomised trial of 6 months Intensified anti-tuberculosis and 2 months antiInflammatory treatment for HIV-Infected and HIV-uninfected African and Asianchildren with tuberculous meningitis: Sure Trial. - SURE
university college londonUC0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age:between29daysand <15 years
- •2.Weight:>=3kg
- •Symptoms compatible with TBM (e.g.fever, vomiting, anorexia, listlessness,headache.
- •3.CSFresult with abnormalities compatible with TBM(elevated cell count and/or protein with
- •or withoutM.tuberculosisdetected by microscopy or GeneXpert).Physician believes thechild needs immediate initiation of anti-TB drugs.
- •4.Known (or pending confirmation of) HIV status
- •5.Parent/legalcarer give informed,written consent
- •6.Agree for aCSF sampleto be collected andprocessed for chemistry, microscopy,Ziehlâ??
- •Nielsenor auramine stain andmycobacterialculture(in process)and,where available,Xpert
- •(GeneXpert/Rif or Xpert Ultra)prior to commencingtreatmentor when clinically stable todo so. Where patients have already been started on ATT, pre-screening CSF resultsshould beavailable
- •7.Participantâ??s carer/parentcan comply with the protocol requirements in the opinion of the
- •site investigator
- •8.Homeaddress accessible for visiting and intending to remain within the recruitment area for
- •follow upperiod ofat least18months
排除标准
- •1.Recent contact(last 12 months)withknown or suspectedrifampicin-resistant TB
- •2.Proven drugresistance to rifampicin in the child
- •3.On ATT for >7 days
- •4.Severely moribund; high risk of death within 24hours
- •5.History or presence of known allergy or other contraindication toany first-line anti-
- •tuberculosisdrugs, corticosteroids, or aspirin
- •6.Pregnancy
- •7.History ofgastrointestinal (GI)bleeding or bleeding diathesis
- •8.Activeclinicalinfection with influenza or varicella
- •9.Grade 4 liver toxicity or other contraindicationsfor taking part in the trial
研究者
相似试验
进行中(未招募)
3 期
SURE: Short intensive treatment for children with tuberculous meningitisInfections and InfestationsTuberculous meningitisISRCTN40829906niversity College London369
已完成
不适用
The effect of inhaled corticosteroids (ICS) on airway inflammation in chronic obstructive pulmonary disease (COPD)chronic obstructive pulmonary disease (COPD)Respiratory - Chronic obstructive pulmonary diseaseACTRN12612001111864GlaxoSmithKline's (GSK)34
已完成
不适用
Effects of Hintonia latiflora in type 2 diabeticsMild and moderate diabetes mellitus of type II (age-related)Nutritional, Metabolic, EndocrineISRCTN83308122Gehrlicher Pharmazeutische Extrakte GmbH (Germany)40
已完成
不适用
Effectiveness of a Herbal and Nutritional Supplement on Cognitive Function in Older Adults with Subjective Cognitive ImpairmentACTRN12617000945325Mrs Adele Cave100
进行中(未招募)
1 期
Efficacy study to evaluate fluticasone furoate /vilanterol Inhalation Powder delivered once daily via the Dry Powder Inhaler Ellipta™ compared with usual ICS/LABA maintenance therapy delivered by Dry Powder Inhaler in subjects with Persistent AsthmaSubject with persistent asthmaMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-000551-81-DEGlaxoSmithKline Research & Development Limited422
